West Pharmaceutical (WST) Misses on Q2 Earnings, Lowers '24 View

The adjustments include expenses related to the amortization of acquisition-related intangible assets. Revenues in Detail The company recorded an organic net sales decline of 5.9% in the reported quarter. Segmental Details Net sales in the Proprietary Products segment were $559.7 million, indicating a decline of 9.4% year over year and 8.4% on an organic basis. HVP net sales, which accounted for more than 70% of the segment's net sales, were driven by customer demand for self-injection, Envision® components ...